These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34955169)

  • 1. Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness.
    Luykx JJ; Loef D; Lin B; van Diermen L; Nuninga JO; van Exel E; Oudega ML; Rhebergen D; Schouws SNTM; van Eijndhoven P; Verwijk E; Schrijvers D; Birkenhager TK; Ryan KM; Arts B; van Bronswijk SC; Kenis G; Schurgers G; Baune BT; Arns M; van Dellen EE; Somers M; Sommer IEC; Boks MP; Gülöksüz S; McLoughlin DM; Dols A; Rutten BPF
    Biol Psychiatry; 2022 Mar; 91(6):531-539. PubMed ID: 34955169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Polygenic Risk Scores and Outcome of ECT.
    Sigström R; Kowalec K; Jonsson L; Clements CC; Karlsson R; Nordenskjöld A; Pålsson E; Sullivan PF; Landén M
    Am J Psychiatry; 2022 Nov; 179(11):844-852. PubMed ID: 36069021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy.
    Foo JC; Streit F; Frank J; Witt SH; Treutlein J; ; Baune BT; Moebus S; Jöckel KH; Forstner AJ; Nöthen MM; Rietschel M; Sartorius A; Kranaster L
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jan; 180(1):35-45. PubMed ID: 30507021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.
    Fanelli G; Domschke K; Minelli A; Gennarelli M; Martini P; Bortolomasi M; Maron E; Squassina A; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Baune BT; ; Serretti A; Fabbri C
    Eur Neuropsychopharmacol; 2022 Feb; 55():86-95. PubMed ID: 34844152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
    Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
    JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Individual Response to Electroconvulsive Therapy via Machine Learning on Structural Magnetic Resonance Imaging Data.
    Redlich R; Opel N; Grotegerd D; Dohm K; Zaremba D; Bürger C; Münker S; Mühlmann L; Wahl P; Heindel W; Arolt V; Alferink J; Zwanzger P; Zavorotnyy M; Kugel H; Dannlowski U
    JAMA Psychiatry; 2016 Jun; 73(6):557-64. PubMed ID: 27145449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Emotional Memory Reactivation vs Control Memory Reactivation Before Electroconvulsive Therapy in Adult Patients With Depressive Disorder: A Randomized Clinical Trial.
    Scheepens DS; van Waarde JA; Ten Doesschate F; Westra M; Kroes MCW; Schene AH; Bockting CLH; Schoevers RA; Denys DAJP; Ruhé HG; van Wingen GA
    JAMA Netw Open; 2020 Aug; 3(8):e2012389. PubMed ID: 32749468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia polygenic risk scores in youth mental health: preliminary associations with diagnosis, clinical stage and functioning.
    Crouse JJ; Carpenter JS; Iorfino F; Lin T; Ho N; Byrne EM; Henders AK; Wallace L; Hermens DF; Scott EM; Wray NR; Hickie IB
    BJPsych Open; 2021 Feb; 7(2):e58. PubMed ID: 33612137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy.
    Lin CH; Chen MC; Yang WC; Lane HY
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):225-233. PubMed ID: 26718791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy.
    Rasmussen KG; Mueller M; Knapp RG; Husain MM; Rummans TA; Sampson SM; O'Connor MK; Petrides G; Fink M; Kellner CH
    J Clin Psychiatry; 2007 Nov; 68(11):1701-6. PubMed ID: 18052563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of Polygenic Risk Scores to Predict Antidepressant Treatment Response in Major Depression: A Systematic Review.
    Meerman JJ; Ter Hark SE; Janzing JGE; Coenen MJH
    J Affect Disord; 2022 May; 304():1-11. PubMed ID: 35151671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assessed remission rates after electroconvulsive therapy of depressive disorders.
    Brus O; Cao Y; Gustafsson E; Hultén M; Landen M; Lundberg J; Nordanskog P; Nordenskjöld A
    Eur Psychiatry; 2017 Sep; 45():154-160. PubMed ID: 28865389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.
    Shapira B; Lidsky D; Gorfine M; Lerer B
    J Clin Psychiatry; 1996 Jan; 57(1):32-8. PubMed ID: 8543545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic heterogeneity in antidepressant treatment and placebo response.
    Nøhr AK; Forsingdal A; Moltke I; Howes OD; Vitezic M; Albrechtsen A; Dalby M
    Transl Psychiatry; 2022 Oct; 12(1):456. PubMed ID: 36309483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
    Lin CH; Huang CJ; Chen CC
    Int J Neuropsychopharmacol; 2018 Jan; 21(1):63-72. PubMed ID: 29228200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine versus electroconvulsive therapy for major depressive episode: An updated systematic review and non-inferiority meta-analysis.
    Petrucci ABC; Fernandes JVA; Reis IA; da Silva GHS; Recla BMF; de Mendonça JC; Pedro VCS; D'Assunção LEN; Valiengo LDCL
    Psychiatry Res; 2024 Sep; 339():115994. PubMed ID: 38865906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.
    Chen F; Sidhom E; Yang S; Ruiz-Mendoza E; Essem J
    BMC Psychiatry; 2021 Jan; 21(1):50. PubMed ID: 33478427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.